TENT5A and COVID-19: Thus, we immunized wild-type and Tent5a−/− mice with mRNA-1273, BNT162b2 or a Nuvaxovid (Novavax) protein-based COVID-19 vaccine, and measured antibody production (14 days after vaccination).